Barnett & Company’s Elanco Animal Health ELAN Stock Holding History

Barnett & Company’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29	Closed	-$1K	–	465
2019 Q3	$1K	Buy	+29	New	+$870	﹤0.01%	361

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barnett & Company's ELAN Position: Q4 2019 in Review

Barnett & Company sold out of Elanco Animal Health (ELAN) in Q4 2019, closing a stake of 29 shares — an estimated $1K sold.

Barnett & Company first reported a position in ELAN in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 400 funds tracked by Wall St. Rank hold ELAN as of Q4 2019.

Barnett & Company reported no remaining Elanco Animal Health position as of Q4 2019 after selling out during the quarter.
Barnett & Company sold 29 Elanco Animal Health shares in Q4 2019, an estimated $1K.
Barnett & Company first reported a position in Elanco Animal Health in Q3 2019 and held it in 1 quarter.
Barnett & Company's Elanco Animal Health position peaked at $1K in Q3 2019.
400 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2019.

Based on Barnett & Company's 13F filing for Q4 2019, filed 22 Jan 2020.